AnaptysBio, Inc. ANAB EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s EPS (diluted)?
- AnaptysBio, Inc. (ANAB) reported EPS (diluted) of -$1.84 in Q1 2026.
- How has AnaptysBio, Inc.'s EPS (diluted) changed year-over-year?
- AnaptysBio, Inc.'s EPS (diluted) decreased by 43.8% year-over-year, from -$1.28 to -$1.84.
- What is the long-term trend for AnaptysBio, Inc.'s EPS (diluted)?
- Over 3 years (2021 to 2024), AnaptysBio, Inc.'s EPS (diluted) has grown at a 34.6% compound annual growth rate (CAGR), from -$2.11 to -$5.15.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.